Cardio-oncology, An Issue of Cardiology Clinics, 1st Edition
In this issue of Cardiology Clinics, guest editors Drs. Eric H. Yang and Ashley F. Stein-Merlob bring their considerable expertise to the topic of Cardio-oncology. Top experts discuss key topics such as anthracycline-induced cardiotoxicity; cardiac complications of immunotherapy: immune checkpoint inhibitors and CAR T cell therapy; advances in diagnosis and treatment of amyloid cardiomyopathy; guidelines in cardio-oncology; and more.
In this issue of Cardiology Clinics, guest editors Drs. Eric H. Yang and Ashley F. Stein-Merlob bring their considerable expertise to the topic of Cardio-oncology. Top experts discuss key topics such as anthracycline-induced cardiotoxicity; cardiac complications of immunotherapy: immune checkpoint inhibitors and CAR T cell therapy; advances in diagnosis and treatment of amyloid cardiomyopathy; guidelines in cardio-oncology; and more.
Key Features
- Contains 18 relevant, practice-oriented topics including permissive cardiotoxicity; advances in imaging of cardiotoxicity; management of cancer therapy-related hypertension; cardiac complications of radiation therapy; health disparities in cardio-oncology; and more.
- Provides in-depth clinical reviews on cardio-oncology, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Author Information
Edited by Eric H. Yang, M.D., FACC, FASE, FAHA, Associate Clinical Professor of Medicine, Director, UCLA Cardio-Oncology Program,Associate Program Director, UCLA/Olive View/West LA VA Cardiovascular Diseases Fellowship, Division of Cardiology, Department of Medicine, University of California, Los Angeles and Ashley F. Stein-Merlob, MD, Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, CA, USA
